Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO dual latency-reversing agent study in adults with suppressed HIV-1
NL-OMON61072Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of topiramate in Human immunodeficiency virus infection type 1, sponsored by Erasmus MC. Started Jul 2026; status: recruiting.
02
Drugs
topiramate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on NL-OMON61072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61072.